Katie Coleman: As long as I’m still writing this story, this isn’t how my story ends
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation and President of the Chromophobe and Oncocytic Tumor Alliance (COA), shared on X:
“On January 20th 2021, just three weeks after a stage IV cancer diagnosis with near impossible odds, I wrote:
‘As long as I’m still writing this story, this isn’t how my story ends.’
I truly can’t believe that now, three weeks from today, I’ll be sharing that story with the world.
I wouldn’t be here if it weren’t for the community of support that surrounded me through my darkest days. This is my small way of giving back to a community that has given so much to me.
I hope it helps others.”
Proceed to the video attached to the post.
More posts featuring Katie Coleman on oncodaily.com
Katie Coleman, Product and Engineering Lead at the Rare Cancer Research Foundation and President of the Chromophobe and Oncocytic Tumor Alliance (COA), is a dedicated software engineer with a mission for creating intuitive, user-friendly products. As a rare kidney cancer survivor, she is deeply committed to medical research and advocacy. Her personal experience helps her to promote collaborations that advance rare cancer research. Katie combines her technical expertise and unique perspective to develop products that improve patient outcomes and support the foundation’s mission.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023